New Drug Approvals Archive - November 2005
Get news by email or subscribe to our news feeds.
November 2005
| November 2 |
Exjade (deferasirox) Dispersible Tablets Date of Approval: November 2, 2005
Company: Novartis
Treatment for: Hemosiderosis, Iron Overload
Exjade (deferasirox) is a once-daily oral iron chelator approved for the
treatment of chronic iron overload due to blood transfusions, and non-transfusion-dependent thalassemia. Exjade (deferasirox) FDA Approval History |
| January 23 |
Exjade (deferasirox)
New Indication Approved: January 23, 2013
Exjade (deferasirox) FDA Approval History |
New Drug Approvals Archive
2016
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2015
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2014
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2013
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2012
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2011
January,
February,
March,
April,
May,
June,
July,
August,
October,
November,
December2010
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2009
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2008
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2007
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2006
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2005
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2004
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2003
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December
